Cambridge platelet startup gets $3.5M DoD grant to treat battlefield casualties

A Cambridge-based biotech startup that's using bioreactors to create human platelets has won a two-year, $3.5 million grant from the U.S. Department of Defense, which hopes the technology could be used to treat wounds on the battlefield. Platelet BioGenesis said Wednesday that the funding would support the development of its bioreactor, which is designed to generate functional platelets — the components of blood cells that help the body to form clots and stop bleeding. In an interview, Platelet…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news